-transparent.png){kind=logo}
The effects of oral doses (100, 200, and 400 mg) of a dopamine derivative, ibopamine, on serum prolactin (PRL) and growth hormone (GH) levels were evaluated in hyperprolactinemic patients, some of whom also were acromegalic. There was dose-related lowering of PRL levels. The highest dose was as effective as 500 mg L-dopa, although the duration of action was shorter, with a decrease to below 50% of basal PRL values in all patients. Serum GH did not rise in nonacromegalic subjects, but it fell after 400 mg ibopamine in the L-dopa-sensitive acromegalic patients. These data suggest, but do not prove, that ibopamine is able to directly stimulate pituitary dopamine receptors.
Related Publications
C Ferrari, and
C Barbieri, and
R Caldara, and
P Rampini, and
A Paracchi, and
M Boghen, and
W G Rauhe
March 1977,
The Journal of clinical endocrinology and metabolism,
C Ferrari, and
C Barbieri, and
R Caldara, and
P Rampini, and
A Paracchi, and
M Boghen, and
W G Rauhe
August 1985,
The Journal of clinical endocrinology and metabolism,
C Ferrari, and
C Barbieri, and
R Caldara, and
P Rampini, and
A Paracchi, and
M Boghen, and
W G Rauhe
October 1989,
Clinical endocrinology,
C Ferrari, and
C Barbieri, and
R Caldara, and
P Rampini, and
A Paracchi, and
M Boghen, and
W G Rauhe
January 1997,
Life sciences,
C Ferrari, and
C Barbieri, and
R Caldara, and
P Rampini, and
A Paracchi, and
M Boghen, and
W G Rauhe
January 1975,
Neuroendocrinology,
C Ferrari, and
C Barbieri, and
R Caldara, and
P Rampini, and
A Paracchi, and
M Boghen, and
W G Rauhe
May 1983,
Acta endocrinologica,
C Ferrari, and
C Barbieri, and
R Caldara, and
P Rampini, and
A Paracchi, and
M Boghen, and
W G Rauhe
January 1978,
Godisen zbornik na Medicinskiot fakultet vo Skopje,
C Ferrari, and
C Barbieri, and
R Caldara, and
P Rampini, and
A Paracchi, and
M Boghen, and
W G Rauhe
August 1976,
The Journal of clinical endocrinology and metabolism,
C Ferrari, and
C Barbieri, and
R Caldara, and
P Rampini, and
A Paracchi, and
M Boghen, and
W G Rauhe
January 1985,
European journal of clinical pharmacology,
C Ferrari, and
C Barbieri, and
R Caldara, and
P Rampini, and
A Paracchi, and
M Boghen, and
W G Rauhe
August 1985,
Acta endocrinologica,
